“I want N-of-1 treatments for humans to be free. I never want to sell a drug” (Image: Simon Kuo)
Biohacker Andrew Hessel‘s open-source drug company aims to make bespoke cancer-fighting viruses using DNA printers – paid for by a Netflix-style subscription
You worked in big pharma. Why did you leave?
More than a decade ago, I was with a large biopharma company where I learned first-hand that drug development wasn’t really working. Putting tremendous resources into R&D didn’t necessarily produce a lot of results, even though we used the most advanced genetic technologies and the best people. I decided…
